AMYLYX PHARMACEUTICALS ($AMLX) posted quarterly earnings results on Tuesday, March 4th. The company reported earnings of -$0.55 per share, missing estimates of -$0.53 by $0.02. The company also reported revenue of $-670,000, missing estimates of $0 by $-670,000.
You can see Quiver Quantitative's $AMLX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMYLYX PHARMACEUTICALS Insider Trading Activity
AMYLYX PHARMACEUTICALS insiders have traded $AMLX stock on the open market 14 times in the past 6 months. Of those trades, 3 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $AMLX stock by insiders over the last 6 months:
- GEORGE M JR MILNE purchased 100,000 shares for an estimated $219,800
- JOSHUA B COHEN (Co-Chief Executive Officer) has made 0 purchases and 3 sales selling 37,911 shares for an estimated $130,753.
- JUSTIN B. KLEE (Co-Chief Executive Officer) has made 0 purchases and 3 sales selling 37,915 shares for an estimated $130,734.
- KAREN FIRESTONE purchased 50,000 shares for an estimated $106,590
- JAMES M FRATES (Chief Financial Officer) purchased 40,000 shares for an estimated $101,367
- CAMILLE L BEDROSIAN (Chief Medical Officer) has made 0 purchases and 2 sales selling 16,863 shares for an estimated $66,566.
- GINA MAZZARIELLO (Chief Legal Officer) has made 0 purchases and 3 sales selling 16,556 shares for an estimated $53,824.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMYLYX PHARMACEUTICALS Hedge Fund Activity
We have seen 65 institutional investors add shares of AMYLYX PHARMACEUTICALS stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PERCEPTIVE ADVISORS LLC added 4,648,699 shares (+218.7%) to their portfolio in Q4 2024, for an estimated $17,572,082
- BANK OF AMERICA CORP /DE/ added 1,513,748 shares (+165.9%) to their portfolio in Q4 2024, for an estimated $5,721,967
- BOXER CAPITAL, LLC removed 1,500,000 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $4,860,000
- ALYESKA INVESTMENT GROUP, L.P. removed 1,200,000 shares (-59.3%) from their portfolio in Q4 2024, for an estimated $4,536,000
- ACADIAN ASSET MANAGEMENT LLC removed 1,158,271 shares (-65.4%) from their portfolio in Q4 2024, for an estimated $4,378,264
- FARALLON CAPITAL MANAGEMENT LLC removed 1,150,221 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $4,347,835
- SATURN V CAPITAL MANAGEMENT LP added 889,073 shares (+inf%) to their portfolio in Q4 2024, for an estimated $3,360,695
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
